Onderneming OliX Pharmaceuticals, Inc
Aandelen
A226950
KR7226950004
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
15.200 KRW | +3,33% | -0,65% | +4,25% |
Vakgebied
Verkoop per activiteit
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 9 320 | 100,0 % | 17 064 | 100,0 % | +83,09% |
Verkoop per regio
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
South Korea
100,0
%
| 9 320 | 100,0 % | 17 064 | 100,0 % | +83,09% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Dong-Gi Lee
FOU | Founder | 52 | 01-02-10 |
Jun-Hyun Park
CTO | Chief Tech/Sci/R&D Officer | 39 | - |
Young-Hye Baek
BRD | Director/Board Member | 49 | - |
Chung-Gil Kang
BRD | Director/Board Member | 53 | - |
Sin-Young Park
BRD | Director/Board Member | 59 | - |
Sung-Hwa Hong
AUD | Comptroller/Controller/Auditor | 67 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yang-Gyoon Kim
BRD | Director/Board Member | 57 | - |
Chang-Soo Yoon
BRD | Director/Board Member | 51 | - |
Dong-Gi Lee
FOU | Founder | 52 | 01-02-10 |
Sin-Young Park
BRD | Director/Board Member | 59 | - |
Chung-Gil Kang
BRD | Director/Board Member | 53 | - |
Young-Hye Baek
BRD | Director/Board Member | 49 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 442 128 | 0 | 0 | 73,23 % |
Aandeel B | 1 | 16 526 595 | 12 102 177 ( 73,23 %) | 0 | |
Aandeel C | 0 | 431 583 | 0 | 0 |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
PCL, INC. 7.65% | 4 132 665 | 7.65% | 3 597 113 $ |
Bedrijfsgegevens
OliX Pharmaceuticals, Inc.
#1014 Ace Gwangkyo Tower1 17 Daehak 4-ro
16226, Suwon-si
+
http://www.olixpharma.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+4,25% | 178 mln. | |
+5,33% | 111 mld. | |
+12,11% | 105 mld. | |
-12,56% | 22,34 mld. | |
-3,70% | 21,93 mld. | |
-6,03% | 18,59 mld. | |
-35,21% | 18,12 mld. | |
-10,86% | 16,96 mld. | |
+5,10% | 13,7 mld. | |
+37,57% | 12,45 mld. |
- Beurs
- Aandelen
- Koers A226950
- Onderneming OliX Pharmaceuticals, Inc